Liggins Institute, The University of Auckland, Auckland, New Zealand.
Nestlé Research, Société des Produits Nestlé SA, Beijing, China.
Clin Nutr. 2023 Dec;42(12):2443-2456. doi: 10.1016/j.clnu.2023.09.009. Epub 2023 Oct 5.
BACKGROUND & AIMS: Optimal maternal vitamin status during pregnancy and lactation is essential to support maternal and infant health. For instance, vitamin D is involved in infant bone development, and B-vitamins are involved in various metabolic processes, including energy production. Through a double-blind randomised controlled trial, we investigated the effects of maternal supplementation from preconception throughout pregnancy until birth on human milk (HM) concentrations of vitamin D and B-vitamins. In addition, we aimed to characterise longitudinal changes in milk concentrations of these vitamins.
Both control and intervention supplements contained calcium, iodine, iron, β-carotene, and folic acid, while the intervention also contained zinc, vitamins B, B, B, and D, probiotics, and myo-inositol. HM samples were collected across 4 time points from 1 week to 3 months post-delivery from 158 mothers in Singapore, and 7 time points from 1 week to 12 months from 180 mothers in New Zealand. HM vitamin D was quantified using supercritical fluid chromatography and B-vitamins with mass spectrometry. Potential intervention effects on HM vitamins D, B, B, and B, as well as other B-vitamin (B and B) concentrations were assessed using linear mixed models with a repeated measures design.
Over the first 3 months of lactation, HM 25-hydroxyvitamin D concentrations were 20% (95% CI 8%, 33%, P = 0.001) higher in the intervention group, with more marked effects in New Zealand. There were no observed intervention effects on HM concentrations of vitamins B, B, B, B, and B. In New Zealand mothers, longitudinally, vitamin D concentrations gradually increased from early lactation up to 12 months, while vitamins B and B peaked at 6 weeks, B at 3 weeks, and B and B at 3 months.
Maternal supplementation during preconception and pregnancy increased HM vitamin D, but not B-vitamin concentrations in lactation. Further studies are required to examine the discrete benefits of vitamin D supplementation starting preconception vs during pregnancy, and to further characterise the effects of supplementation on later offspring health outcomes.
Registered at ClinicalTrials.gov on the 16 July 2015 (identifier NCT02509988); Universal Trial Number U1111-1171-8056. This study was academic-led by the EpiGen Global Research Consortium.
孕期和哺乳期母体最佳维生素状态对于支持母婴健康至关重要。例如,维生素 D 参与婴儿骨骼发育,B 族维生素参与各种代谢过程,包括能量产生。通过一项双盲随机对照试验,我们研究了从受孕前到分娩期间母亲补充剂对人乳(HM)中维生素 D 和 B 族维生素浓度的影响。此外,我们旨在描述这些维生素在乳中的纵向变化。
对照组和干预组补充剂均含有钙、碘、铁、β-胡萝卜素和叶酸,而干预组还含有锌、维生素 B、B、B 和 D、益生菌和肌醇。从新加坡的 158 位母亲分娩后 1 周到 3 个月内,以及从新西兰的 180 位母亲分娩后 1 周到 12 个月内,采集了 4 个时间点的 HM 样本。使用超临界流体色谱法对 HM 维生素 D 进行定量,用质谱法对 B 族维生素进行定量。使用具有重复测量设计的线性混合模型评估潜在干预措施对 HM 维生素 D、B、B 和 B 以及其他 B 族维生素(B 和 B)浓度的影响。
在哺乳的头 3 个月里,干预组的 HM 25-羟维生素 D 浓度高 20%(95%CI 8%,33%,P=0.001),新西兰的效果更为显著。在 HM 浓度中,没有观察到维生素 B、B、B、B 和 B 的干预作用。在新西兰母亲中,纵向观察,维生素 D 浓度从早期哺乳期逐渐增加到 12 个月,而维生素 B 和 B 在 6 周时达到峰值,B 在 3 周时达到峰值,B 和 B 在 3 个月时达到峰值。
受孕前和妊娠期间的母体补充增加了 HM 中的维生素 D,但没有增加哺乳期的 B 族维生素浓度。需要进一步研究以确定从受孕前开始补充维生素 D 与在妊娠期间补充维生素 D 的独特益处,并进一步描述补充剂对后代后期健康结果的影响。
于 2015 年 7 月 16 日在 ClinicalTrials.gov 注册(标识符 NCT02509988);通用试验编号 U1111-1171-8056。这项研究是由 EpiGen 全球研究联盟主导的学术研究。